搜索医生

Yael N. Kusne, M.D., Ph.D.

  1. Hematologist

出版物

  1. Sullivan M, Mead-Harvey C, Sartori-Valinotti JC, Kalantari K, Kusne YN, Patnaik M, Mangaonkar AA, Go R, Montes D, Reichard K, Olteanu H, Bois M, Hines A, Warrington K, Koster MJ. Vasculitis associated with VEXAS syndrome. Rheumatology (Oxford). 2024 Oct 11 [Epub ahead of print]
    View PubMed
  2. Kalantari K, Sullivan MM, Hernandez LPH, Bu L, Cornell LD, Nasr SH, Fervenza FC, Montes D, Mangaonkar AA, Go RS, Kusne YN, Patnaik MM, Lasho TL, Olteanu H, Reichard KK, Warrington KJ, Koster MJ. Acute kidney injury, an underrecognized feature of VEXAS syndrome. Rheumatology (Oxford). 2024 Aug 26 [Epub ahead of print]
    View PubMed
  3. Kusne Y, Lasho T, Finke C, Elsabbagh Z, McCue S, Hobday T, Starr J, Bekaii-Saab T, Halfdanarson TR, Patnaik MM, Ou FS, Sonbol MB. Clonal Hematopoiesis in Patients With Neuroendocrine Tumor Treated With Lutetium-177 and the Risk of Thrombocytopenia: A Prospective Study. JCO Precis Oncol. 2024 Jun; 8:e2400143
    View PubMed
  4. Kusne Y, Ghorbanzadeh A, Dulau-Florea A, Shalhoub R, Alcedo PE, Nghiem K, Ferrada MA, Hines A, Quinn KA, Panicker SR, Ombrello AK, Reichard K, Darden I, Goodspeed W, Durrani J, Wilson L, Olteanu H, Lasho T, Kastner DL, Warrington KJ, Mangaonkar A, Go RS, Braylan RC, Beck DB, Patnaik MM, Young NS, Calvo KR, Casanegra AI, Grayson PC, Koster MJ, Wu CO, Kanthi Y, Patel BA, Houghton DE, Groarke EM. Venous and arterial thrombosis in patients with VEXAS syndrome. Blood. 2024 May 23; 143 (21):2190-2200
    View PubMed
  5. Gutierrez-Rodrigues F, Kusne Y, Fernandez J, Lasho T, Shalhoub R, Ma X, Alessi H, Finke C, Koster MJ, Mangaonkar A, Warrington KJ, Begna K, Xie Z, Ombrello AK, Viswanatha D, Ferrada M, Wilson L, Go R, Kourelis T, Reichard K, Olteanu H, Darden I, Hironaka D, Alemu L, Kajigaya S, Rosenzweig S, Calado RT, Groarke EM, Kastner DL, Calvo KR, Wu CO, Grayson PC, Young NS, Beck DB, Patel BA, Patnaik MM. Spectrum of clonal hematopoiesis in VEXAS syndrome. Blood. 2023 Jul 20; 142 (3):244-259
    View PubMed
  6. Fonseca R, Arribas M, Wiedmeier-Nutor JE, Kusne YN, Gonzalez Velez M, Kosiorek HE, Butterfield RDJ, Kirsch IR, Mikhael JR, Stewart AK, Reeder C, Larsen J, Bergsagel PL, Fonseca R. Correction: Integrated analysis of next generation sequencing minimal residual disease (MRD) and PET scan in transplant eligible myeloma patients. Blood Cancer J. 2023 May 26; 13 (1):87
    View PubMed
  7. Ernani V, Appiah AK, Rodriguez D, Kusne Y, Beamer SE, Ravanbakhsh S, Jaroszewski D, Reck Dos Santos P, Sio TT, Yu N, Yang P, Schild S, D'Cunha J. Lobar versus sublobar resection for atypical lung carcinoid: An analysis from the National Cancer Database. Cancer. 2023 Mar 15; 129 (6):860-866 Epub 2022 Dec 22
    View PubMed
  8. Fonseca R, Arribas M, Wiedmeier-Nutor JE, Kusne YN, Gonzalez Velez M, Kosiorek HE, Butterfield RDJ, Kirsch IR, Mikhael JR, Stewart AK, Reeder C, Larsen J, Bergsagel PL, Fonseca R. Integrated analysis of next generation sequencing minimal residual disease (MRD) and PET scan in transplant eligible myeloma patients. Blood Cancer J. 2023 Mar 6; 13 (1):32 Epub 2023 Mar 06
    View PubMed
  9. Gagnon MF, Tian S, Geyer S, Sharma N, Vachon CM, Kusne Y, Bergsagel PL, Stewart AK, Rajkumar SV, Kumar S, Ailawadhi S, Baughn LB. Distribution of clonal hematopoiesis of indeterminate potential (CHIP) is not associated with race in patients with plasma cell neoplasms. Blood Cancer J 2022 Jul 26; 12 (7):112 Epub 2022 July 26
    View PubMed
  10. Kusne Y, Xie Z, Patnaik MM. Clonal hematopoiesis: Molecular and clinical implications. Leuk Res. 2022 Feb; 113:106787 Epub 2022 Jan 10
    View PubMed
  11. Kusne Y, Fernandez J, Patnaik MM. Clonal hematopoiesis and VEXAS syndrome: survival of the fittest clones? Semin Hematol. 2021 Oct; 58 (4):226-229 Epub 2021 Oct 09
    View PubMed
  12. Botrus G, Kosirorek H, Sonbol MB, Kusne Y, Uson Junior PLS, Borad MJ, Ahn DH, Kasi PM, Drusbosky LM, Dada H, Surapaneni PK, Starr J, Ritter A, McMillan J, Wylie N, Mody K, Bekaii-Saab TS. Circulating Tumor DNA-Based Testing and Actionable Findings in Patients with Advanced and Metastatic Pancreatic Adenocarcinoma. Oncologist. 2021 Jul; 26 (7):569-578 Epub 2021 Mar 05
    View PubMed
  13. Kusne YN, Kosiorek HE, Buras MR, Verona PM, Coppola KE, Rone KA, Cook CB, Karlin NJ. Implications of neuroendocrine tumor and diabetes mellitus on patient outcomes and care: a matched case-control study. Future Sci OA. 2021 Feb 15; 7 (5):FSO684
    View PubMed
  14. Sagaser S, Butterfield R, Kosiorek H, Kusne Y, Maldonado J, Fautsch MP, Patel D, Shen JF. Effects of Intense Pulsed Light on Tear Film TGF-beta and Microbiome in Ocular Rosacea with Dry Eye. Clin Ophthalmol. 2021; 15:323-330 Epub 2021 Jan 27
    View PubMed
  15. Kusne Y, Christiansen M, Conley C, Gea-Banacloche J, Sen A. Hemophagocytic Lymphohistiocytosis Secondary to Disseminated Histoplasmosis in Rheumatologic Disease. Case Rep Crit Care. 2021; 2021:6612710 Epub 2021 Jan 22
    View PubMed
  16. Kusne YN, Kosiorek HE, Buras MR, Coppola KE, Verona PM, Cook CB, Karlin NJ. Mortality and glycemic control among patients with diabetes mellitus and uterine or ovarian cancer. Future Sci OA. 2020 Dec 18; 7 (3):FSO670
    View PubMed
  17. Gonzalez-Velez M, Mead-Harvey C, Kosiorek HE, Kusne YN, Rivera C, Bojanini L, Northfelt DW, Padrnos LJ. Racial/ethnic differences in patients with anemia and folate deficiency. Int J Lab Hematol. 2020 Aug; 42 (4):403-410 Epub 2020 Apr 16
    View PubMed
  18. Kusne Y, Kimes KE, Feller FF, Patron R, Banacloche JG, Blair JE, Vikram HR, Ampel NM. Coccidioidomycosis in Patients Treated With Ruxolitinib. Open Forum Infect Dis. 2020 Jun; 7 (6):ofaa167 Epub 2020 May 19
    View PubMed
  19. Kusne Y, Wolf AB, Townley K, Conway M, Peyman GA. Visual system manifestations of Alzheimer's disease. Acta Ophthalmol. 2017 Dec; 95 (8):e668-e676 Epub 2016 Nov 19
    View PubMed
  20. Kusne Y, Temkit M, Khera N, Patel DR, Shen JF. Conjunctival subepithelial fibrosis and meibomian gland atrophy in ocular graft-versus-host disease. Ocul Surf. 2017 Oct; 15 (4):784-788 Epub 2017 Aug 05
    View PubMed
  21. Mirzadeh Z, Kusne Y, Duran-Moreno M, Cabrales E, Gil-Perotin S, Ortiz C, Chen B, Garcia-Verdugo JM, Sanai N, Alvarez-Buylla A. Bi- and uniciliated ependymal cells define continuous floor-plate-derived tanycytic territories. Nat Commun. 2017 Jan 9; 8:13759 Epub 2017 Jan 09
    View PubMed
  22. Kusne Y, Kang P, Fintelmann RE. A retrospective analysis of intraocular pressure changes after cataract surgery with the use of prednisolone acetate 1% versus difluprednate 0.05%. Clin Ophthalmol. 2016; 10:2329-2336 Epub 2016 Nov 23
    View PubMed
  23. Ampie L, Kusne Y, Sanai N. The evolving genomic landscape of recurrent gliomas. World Neurosurg 2015 May; 83 (5):722-3 Epub 2015 Mar 10
    View PubMed
  24. Kusne Y, Sanai N. The SVZ and Its Relationship to Stem Cell Based Neuro-oncogenesis. Adv Exp Med Biol. 2015; 853:23-32
    View PubMed
  25. Kusne Y, Carrera-Silva EA, Perry AS, Rushing EJ, Mandell EK, Dietrich JD, Errasti AE, Gibbs D, Berens ME, Loftus JC, Hulme C, Yang W, Lu Z, Aldape K, Sanai N, Rothlin CV, Ghosh S. Targeting aPKC disables oncogenic signaling by both the EGFR and the proinflammatory cytokine TNFalpha in glioblastoma. Sci Signal. 2014 Aug 12; 7 (338):ra75
    View PubMed
  26. Mirzadeh Z, Bina R, Kusne Y, Coons SW, Spetzler RF, Sanai N. Predictors of functional recovery in adults with posterior fossa ependymomas. J Neurosurg. 2014 May; 120 (5):1063-8 Epub 2014 Feb 28
    View PubMed
  27. Kusne Y, Goldberg EL, Parker SS, Hapak SM, Maskaykina IY, Chew WM, Limesand KH, Brooks HL, Price TJ, Sanai N, Nikolich-Zugich J, Ghosh S. Contrasting effects of chronic, systemic treatment with mTOR inhibitors rapamycin and metformin on adult neural progenitors in mice. Age (Dordr). 2014 Feb; 36 (1):199-212 Epub 2013 Aug 16
    View PubMed
  28. Parker SS, Mandell EK, Hapak SM, Maskaykina IY, Kusne Y, Kim JY, Moy JK, St John PA, Wilson JM, Gothard KM, Price TJ, Ghosh S. Competing molecular interactions of aPKC isoforms regulate neuronal polarity. Proc Natl Acad Sci U S A. 2013 Aug 27; 110 (35):14450-5 Epub 2013 Aug 12
    View PubMed
  29. Wolf AB, Braden BB, Bimonte-Nelson H, Kusne Y, Young N, Engler-Chiurazzi E, Garcia AN, Walker DG, Moses GS, Tran H, LaFerla F, Lue L, Emerson Lombardo N, Valla J. Broad-based nutritional supplementation in 3xTg mice corrects mitochondrial function and indicates sex-specificity in response to Alzheimer's disease intervention. J Alzheimers Dis. 2012; 32 (1):217-32
    View PubMed
  30. Nicholson RM, Kusne Y, Nowak LA, LaFerla FM, Reiman EM, Valla J. Regional cerebral glucose uptake in the 3xTG model of Alzheimer's disease highlights common regional vulnerability across AD mouse models. Brain Res. 2010 Aug 6; 1347:179-85
    View PubMed
  31. Valla J, Yaari R, Wolf AB, Kusne Y, Beach TG, Roher AE, Corneveaux JJ, Huentelman MJ, Caselli RJ, Reiman EM. Reduced posterior cingulate mitochondrial activity in expired young adult carriers of the APOE epsilon4 allele, the major late-onset Alzheimer's susceptibility gene. J Alzheimers Dis. 2010; 22(1):307-13.
    View PubMed
PST-20578241